[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$faTdNqdenxlR4ilVBbQKG2Lhp8LjAM6syxOZyJzCee7I":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":30,"type":31},[],"2024-06-22 14:31:28",154305081,[8,9,10,11],"糖基修饰脂质体","聚乳酸微球","静脉注射用乳剂","氰基丙烯酸烷酯纳米囊",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},15,"62d1377c1c2ce2437509be2b4611b125","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002Fc5241136494e70de8f5cb5a0d306f0c1.png","药物制剂技术","c852cb43f08f440ea4f7e9a0cc6f06e2","项目十三章节测验","属于主动靶向制剂的是",[21,32,41,50,59,68,77,86,89,98],{"answer":22,"createTime":5,"id":23,"options":24,"question":29,"source":30,"type":31},[],154305067,[25,26,27,28],"背衬层","药物贮库","控释膜","粘附层","经皮给药制剂中既能提供释放的药物,又能供给释药的能量的是","v1",0,{"answer":33,"createTime":5,"id":34,"options":35,"question":40,"source":30,"type":31},[],154305069,[36,37,38,39],"不受胃肠道pH等影响","无首过效应","不受角质层屏障干扰","释药平稳","下列透皮治疗体系(TTS)的叙述哪种是错误的",{"answer":42,"createTime":5,"id":43,"options":44,"question":49,"source":30,"type":31},[],154305071,[45,46,47,48],"一般而言,药物穿透皮肤的能力是水溶性药物大于油溶性溶液","药物的吸收速度与相对分子质量成反比","低熔点的药物容易渗透通过皮肤","一般完全溶解呈饱和状态的药液,透过过程易于进行","关于影响药物的透皮吸收的因素叙述错误的是",{"answer":51,"createTime":5,"id":52,"options":53,"question":58,"source":30,"type":31},[],154305073,[54,55,56,57],"靶向制剂又叫自然靶向制剂","靶向制剂是指进入体内的载药微粒被巨噬细胞摄取,通过正常生理过程运至肝、脾等器官的剂型","靶向制剂是利用某种物理或化学的方法使靶向制剂在特定部位发挥药效的制剂","靶向制剂是通过载体使药物浓集于病变的给药系统","下列关于靶向制剂的概念正确的描述是",{"answer":60,"createTime":5,"id":61,"options":62,"question":67,"source":30,"type":31},[],154305075,[63,64,65,66],"靶向性","缓释性","降低药物毒性","放置很稳定","脂质体不具有的特性是",{"answer":69,"createTime":5,"id":70,"options":71,"question":76,"source":30,"type":31},[],154305077,[72,73,74,75],"吐温80、胆固醇","磷脂、胆固醇","司盘80、磷脂","司盘80、胆固醇","脂质体的骨架材料是",{"answer":78,"createTime":5,"id":79,"options":80,"question":85,"source":30,"type":31},[],154305079,[81,82,83,84],"减少溶出","片外渗透压大于片内,将片内药物压出","减慢扩散","片内渗透压大于片外,将片内药物压出","渗透泵型片剂控释的机理是",{"answer":87,"createTime":5,"id":6,"options":88,"question":19,"source":30,"type":31},[],[8,9,10,11],{"answer":90,"createTime":5,"id":91,"options":92,"question":97,"source":30,"type":31},[],154305083,[93,94,95,96],"表皮途径","皮肤附属器途径","不完整表皮途径","淋巴途径","药物经皮吸收的主要途径",{"answer":99,"createTime":5,"id":100,"options":101,"question":106,"source":30,"type":31},[],154305085,[102,103,104,105],"<1h","2~8h","24h","15h","最适合制备缓控释制剂的药物半衰期为"]